DELIVERY ORDER
Active75N98026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$159.1K
obligated · signed 1 month ago
REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR CONGENITAL MYASTHENIC SYNDROMES
Performance timeline
Start
Sep 1, 2026
End
Aug 31, 2029
with all options
Loading status
Estimated start: Aug 31, 2028
CCS ASSOCIATES, INC.
Contract 75N98026F00001
UEI
VCNRS52G5PG7
Parent Company
CCS ASSOCIATES, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 17
Current Obligation
$159,116
Base + Exercised Options
$159,116
Total Ceiling Value
$159,116
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PSC
SUPPORT- PROFESSIONAL: OTHER
Place of Performance
Congressional District: 17
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NCATS
Office
Contract Vehicle
75N95022D00013
IDCDepartment of Health and Human Services
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.